DMC Biotechnologies

Two climbers ascending a lichen-covered granite slab
DMC Biotechnologies logo
Life Sciences

DMC Biotechnologies ferments engineered microbes to produce amino acids at industrial scale and pharmaceutical purity.

CO-INVESTOR

Sofinnova Partners, Capricorn Ventures
January 31, 2022

Subsequent Close of Series B Financing, Total Raised $39 million

31 January 2022 – DMC Biotechnologies, Inc. announces that strategic investors Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million.

Read more
December 3, 2021

Matt Lipscomb on DMC's Series B Fundraising

See the following link for a video from Matt Lipscomb, CEO, discussing the latest Series B fundraising. https://www.linkedin.com/posts/dmcbio_matt-lipscomb-on-dmcs-series-b-fundraising-activity-6872483117194612736-F2rt/

Read more
December 2, 2021

DMC Announces First Close of Series B Financing, Raising $34 million

2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin.

Read more
May 19, 2021

DMC Biotechnologies completes downstream processing for L-alanine

DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. Processing was done at EW Biotech in Leuna, Germany, following the successful demonstration of commercial scale fermentation at the same site in March.

Read more
February 8, 2020

DMC Biotech Completes Successful Pilot of L-alanine

DMC Biotechnologies has successfully produced its lead product, L-alanine at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3 scale fermentation and for each of the downstream purification unit operations. The robustness of DMC’s Dynamic Metabolic Control technology to the process environment was also validated.

Read more